<div class="entities" style="line-height: 2.5; direction: ltr">Admission Date:  [**2120-10-4**]              Discharge Date:   [**2120-10-23**]<br><br>Date of Birth:  [**2059-2-8**]             Sex:   M<br><br>Service: MEDICINE<br><br>Allergies:<br>Patient recorded as having No Known Allergies to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Drugs
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br>Attending:[**First Name3 (LF) 5552**]<br>Chief Complaint:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diarrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br><br>Major Surgical or Invasive Procedure:<br>None<br><br>History of Present Illness:<br>61 yo man w/ h/o rectal CA and HTN who presents c/o diarrhea x 5<br>days (started on [**9-30**]). Patient reports persistent, non-bloody,<br>watery 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diarrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 every 10-30 minutes.  Denies abdominal pain,<br>fever, chills, N/V, cough, rash, dysuria, sick contacts, or<br>recent travel.  No recent medication changes, no 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>recently.  Has not eaten in restaraunts recently.  H/o similar<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diarrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 in the past which he says was due to 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chemo
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br>.<br>In the ED, patient's lactate was initially 4.0 and he was<br>tachycardic at 110.  Normotensive at 124/80.  Apparently, he<br>refused central line (sepsis protocol).  Received 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 through<br>peripheral 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IV
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
, and repeat lactate was 2.4.  His HR also<br>stabilized in the 80's.  BP remained normal.  While in the ED,<br>he 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    spiked
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    to
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    101
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 so he was given 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Cefepime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vanco
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    flagyl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br>CT of the abdomen and he was admitted to OMED for further<br>observation.<br>.<br><br><br>Past Medical History:<br>1. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Rectal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    metastatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    adenocarcinoma
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 with A lytic lesion in T11<br>dx in [**2120-3-22**], CEA was elevated at 329---&gt;1207 ([**2120-8-20**]).<br>s/p 13 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    XRT
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    therapies
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
. Treated with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Avastin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 (
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bevacizumab
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
), 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5FU
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
,<br>and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Leucovorin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Last treatment [**2120-9-25**].  Oncologist: Dr. [**First Name4 (NamePattern1) **]<br>[**Last Name (NamePattern1) **]<br>2. 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hypertension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br><br><br>Social History:<br>Originally from [**Location (un) 6847**], moved to USA about 30 years ago.<br>Married.  Former restaurant worker, not working presently.  Has<br>a 35 pack year smoking history, quit ~[**2118**]. Rarely drinks<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    alcohol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.<br><br>Family History:<br>Non-contributory<br><br>Physical Exam:<br>VS: T=98.6 (Tm=101.3); BP=155/82; HR=88; RR=11; O2=98% (RA)<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GEN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: elderly asian man, NAD<br>HEENT: PERRL OU, MMM, OP clear, no icterus<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NECK
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: no JVD<br>CV: RRR, NL S1/S2, no murmurs appreciated on exam, no S3/S4<br>heard<br>RESP: CTA, no W/R/R<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ABD
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: NABS, soft, NT, ND, no masses<br>EXT: no edema<br>RECTAL: guaiac negative per ED<br>NEURO: A&amp;Ox3, CN II-XII intact bilat, motor/sensory exam intact<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bilat
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br><br>Pertinent Results:<br>GLUCOSE-153 UREA N-16 CREAT-0.7 SODIUM-135 POTASSIUM-3.0<br>CHLORIDE-107 TOTAL CO2-20 ANION GAP-11<br>CALCIUM-6.9 PHOSPHATE-1.4 MAGNESIUM-2.3<br>.<br>WBC-1.2 RBC-4.07 HGB-11.8 HCT-33.0 MCV-81 MCH-29.0 MCHC-35.7<br>RDW-18.3 PLT COUNT-153<br>.<br>PT-15.6 PTT-27.9 INR(PT)-1.7<br>.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GRAN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 CT-780<br>.<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    LACTATE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-1.7<br>.<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    URINE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
  
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    COLOR
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Yellow
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 APPEAR-Clear SP [**Last Name (un) 155**]-1.021<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    URINE
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
  BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-TR<br>BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG RBC-0 WBC-0-2<br>BACTERIA-RARE YEAST-NONE EPI-0-2<br><br>Brief Hospital Course:<br>61 y/o male with 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    metastatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rectal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    ca
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 diagnosed [**3-26**] s/p xrt<br>(last [**6-25**]) and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chemo
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 (last [**2120-9-25**]) who was admitted with<br>diarrhea, fever, and neutropenia who developed hypoxemia, lactic<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
, and 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    confusion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
.  Since his admission, the patient's<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diarrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fevers
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 had progressively improved on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cefepime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
,<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vancomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    metronidazole
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 as well as 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lomotil
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  Since then<br>his course has been complicated by a steadily declining<br>hematocrit (33 to 25 over the admission), worsening<br>
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    thrombocytopenia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
, and a new 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coagulopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 (INR up 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    to
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>

<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
4).  On<br>[**10-12**], he was noted to be 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypoxemic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and had chest x-ray showing<br>only a distended stomach and a CTA with no PE (but also a<br>distended stomach and known liver mets).  ABG was 7.44/25/63<br>then 7.32/21/84 that afternoon.  His 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    oxygen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 requirement waxed<br>and waned, from mid 80's on room air to mid 90's on room air.<br>His 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypoxemia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 persisted and the patient became increasingly<br>tired, confused, and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    tachypneic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.  A repeat ABG was 7.3/19/75 but<br>his lactate had climbed from 3.5 to 8.0. He was transferred to<br>the ICU at which time he was fatigued and appeared 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disoriented
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
.<br>In this setting, he denied pain (including abdominal) as well as<br>dyspnea despite obvious tachypnea and mild accessory muscle use.<br>He was started on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 with 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    3
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    amps
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bicarb
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, lactate trended down,<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 resolving. CT abdomen showed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with no obvious cut<br>off for obstruction a NGT placed and medical management<br>recommeneded by surgery. Primary oncologist Dr. [**Last Name (STitle) **]<br>continued to follow.<br>  In the ICU he was found to have 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    guiaic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    positive
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 NGT<br>secretions.  He was 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    transfused
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PRBCs
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 for a 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dropping
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    HCT
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  In<br>addition he was noted to have an 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    elevated
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    INR
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 for which he was<br>treated with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    FFP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  He was evaluated by surgery who felt him to<br>be a poor surgical candidate.  For his 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    confusion
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 a CT of his<br>head was performed which was negative for bleed or other change.<br> His hypoxia resolved and was felt to be due to aspiration<br>initially.  He was treated with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    TPN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 given his poor nutritional<br>status.  He was treated with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    octroetide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 per surgery recs with no<br>improvement.  On [**2120-10-18**] a family meeting was held at which<br>time it was decided that the goal of care was maximal comfort.<br>At that meeting it was decided to continue with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fluids
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    analgesia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 but to limit other medications and TPN.  The family<br>will provide 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Chinese
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    herbs
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 and prayer.<br>.<br># GI: 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Diarrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 was believed to be 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chemo
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
-induced 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diarrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
.  The<br>patient was covered with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cefepime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vancomycin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    flagyl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 given<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    neutropenic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    fever
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.  The CT of abdomen on admission did not show<br>any 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    inflammatory
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    processes
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    in
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    the
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    abdomen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. The patient was given<br>supportive care with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lomotil
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 once obtained stool samples<br>for cultures which were negative and his 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    diarrhea
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 improved with<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lomotil
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
.  However, patient became 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidotic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 and CT abdomen was<br>repeated and revealed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. NGT was placed and surgey was<br>consulted but did not feel that the patient was a good surgical<br>candidate. Patient was continued on medical management.<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Octreotide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was added to his regimen to help to relieve<br>obstruction. His lactate continued to trend down and NGT outout<br>began to slow. Patient denied any abdominal pain.<br>    However, while in the ICU he developed 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bloody
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stools
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 in the<br>setting of 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coagulopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
. This was felt to be likely secondary to<br>his 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rectal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cancer
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. He was 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    tranfused
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pRBCs
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    FFP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. After several<br>bloody 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stools
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 and rectal tube placement his bloody bowel<br>movements slowed, his coags improved and his hematocrit was<br>stable.<br>.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Coagulopathy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: Likely 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DIC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 secondary to cancer. He devloped GI<br>bleed as mentioned above and was transfused several 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    units
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 of 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    FFP
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pRBCs
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    unit
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 of 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    platelets
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. By tranfer from the ICU his<br>HCT and INR was stable but platelets were 34. The patient and<br>family did not want any further transfusions as their goal was<br>comfort and this would require daily monitoring of his CBC and<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    coags
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    NEUTROPENIC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    FEVER
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: The patient was started on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cefepime
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
, 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    vanco
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
,<br>and 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    flagyl
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 on admission. He had some fevers early in his<br>hospitalization but remained afebrile for the rest of his<br>admission. He because hypoxic and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidotic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and a CT chest was<br>otained which revealed likely 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    aspiration
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>

<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    pneumonia
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. He was<br>continue on his 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotics
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 to complete a 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    14
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Duration</span>
</mark>
 
<mark class="entity" style="background: rgb(46, 204, 113); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Duration</span>
</mark>
 course and<br>received 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    daily
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    neupogen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    injections
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
. By the 11th day of his<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    antibiotic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 course he was no longer neutropenic. His 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    neupogen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was<br>discontinued and he remained afebrile.<br><br># AG METABOLIC ACIDOSIS: concerning for 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 [**1-24**] to<br>hypovolemia.  Patient refused central line/sepsis protocol in<br>ED. He was  hemodynamically stable on transfer to the floor.<br>Lactate normalized after 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
. Then the patient continued to have<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    non
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
-anion 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    gap
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 [**1-24**] to diarrhea.  ABG was obtained and<br>the patient appropriately compensated with decreased CO2 (25)<br>with normal pH 7.4-7.44. He then became more 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hypoxic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidotc
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
<br>and was tranferred to the ICU. In the ICU it was discoved that<br>he had an extremely 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    dilated
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    stomach
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. It was felt that<br>the 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    lactic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    acidosis
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-ADE</span>
</mark>
 ,may have been secondary to the extreme<br>distension of his stomach given the rapid decline in his lactate<br>on 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    decompression
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 with NGT. His gap closed and his lactate<br>conitnued to tened down.<br>.<br># 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    RECTAL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    CANCER
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
: Last 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chemotherapy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was last 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    avastin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>

<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5FU
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 on [**9-25**].<br>Given that he did not tolerate this well, no further<br>
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    chemotherapy
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 was planned. He also developed what is believed to<br>be lower 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    GI
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-ADE</span>
</mark>
 
<mark class="entity" style="background: rgb(94, 164, 80); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bleed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-ADE</span>
</mark>
, 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 and 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DIC
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
 during admission all which were<br>thaough to be related to his 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    metastatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    disease
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
. Due to his poor<br>prognosis and worsening medical condition a family meeting was<br>held and the family and patient agreed that comfort was the most<br>important goal at this point. He was continued on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 and the<br>NGGT was kept in place to prevent worsening pain from his SBO.<br>It was decided that no further 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    blood
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    products
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 would be given.<br>.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    FEN
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
: Patient was actively hydrated in the setting of diarrhea<br>and acidosis. He was continued on 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 given his 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
. Given his<br>poor prognosis and that comfort was the goal, he was not started<br>on TPN, but rather hydrated with 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    IVF
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 in the setting of 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    SBO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br><br>Medications on Admission:<br>1. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Aspirin
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    325
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    DAILY
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>2. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Atenolol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    50
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    once
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    a
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    day
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>3. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Buspirone
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Compazine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    prn
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br><br><br>Discharge Medications:<br>1. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Acetaminophen
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    325
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablets
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q4
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    -
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (every<br>4 to 6 hours) as 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>2. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Prochlorperazine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    10
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    PO
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q6H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
<br>(
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>3. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Albuterol
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Sulfate
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    083
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Solution
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
)  
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Inhalation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q4H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>4. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Ipratropium
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Bromide
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    02
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    %
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Solution
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 (
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>
)  
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Inhalation
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
<br>
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q6H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    6
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>5. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Dolasetron
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    12
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    625
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Solution
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: One (1)<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Intravenous
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
  
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q8H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    8
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>

<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    as
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>6. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Pantoprazole
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    40
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Recon
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Soln
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    One
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    (
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    1
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Dosage</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    )
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Dosage</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Recon
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Soln
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Form</span>
</mark>
<br>
<mark class="entity" style="background: rgb(149, 165, 166); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Intravenous
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Route</span>
</mark>
  
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q12H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    12
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    hours
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
).<br>7. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Morphine
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Syringe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: [**12-24**]  
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Injection
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q4H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>hours) as 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br>8. 
<mark class="entity" style="background: rgb(52, 152, 219); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Lorazepam
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Drug</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    2
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    /
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mL
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Syringe
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 Sig: 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    0
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    .
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>

<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    5
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(230, 126, 34); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    mg
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Strength</span>
</mark>
 
<mark class="entity" style="background: rgb(155, 89, 182); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Injection
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Form</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Q4H
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Frequency</span>
</mark>
 (
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    every
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Frequency</span>
</mark>
 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    4
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
<br>hours) as 
<mark class="entity" style="background: rgb(241, 196, 15); padding: 0.45em 0.6em; margin: 0 0.25em;  border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    needed
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Frequency</span>
</mark>
.<br><br><br>Discharge Disposition:<br>Extended Care<br><br>Facility:<br>[**Hospital1 2670**] - [**Location (un) **]<br><br>Discharge Diagnosis:<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Metastatic
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    rectal
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    cancer
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Small
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">B-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    bowel
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">I-Reason</span>
</mark>
 
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    obstruction
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">L-Reason</span>
</mark>
.<br>
<mark class="entity" style="background: rgb(211, 84, 0); padding: 0.45em 0.6em; margin: 0 0.25em; border-radius: 0.35em; box-shadow: 2px 4px 6px rgba(0, 0, 0, 0.699);">
    Hypertension
    <span style="font-size: 0.8em; font-weight: bold;  border-radius: 0.35em; vertical-align: middle; margin-left: 0.5rem">U-Reason</span>
</mark>
.<br><br><br>Discharge Condition:<br>Stable.  He is appropriate and interactive.  The goal of care is<br>comfort.<br><br><br>Discharge Instructions:<br>Please take all medications as prescribed.  The goal of care is<br>comfort.<br><br>Followup Instructions:<br>You have the following follow-up appointments<br>Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 593**], MD Phone:[**Telephone/Fax (1) 22**]<br>Date/Time:[**2120-10-30**] 10:00<br>Provider: [**Name Initial (NameIs) 4426**] 22  Date/Time:[**2120-10-30**] 10:30<br>Provider: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 10384**], RN Phone:[**Telephone/Fax (1) 22**]<br>Date/Time:[**2120-10-30**] 10:30<br><br><br><br>Completed by:[**2120-10-23**]</div>